Epkinly (epcoritamab-bysp) — Medica
Diffuse large B-cell lymphoma (DLBCL), including DLBCL not otherwise specified, DLBCL arising from indolent lymphoma, and high-grade B-cell lymphoma
Initial criteria
- age ≥ 18 years
- has received one or more lines of systemic therapy
- prescribed by or in consultation with an oncologist
Approval duration
1 year